Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,918.50
Bid: 1,925.50
Ask: 1,927.00
Change: 0.00 (0.00%)
Spread: 1.50 (0.078%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,918.50
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Weak pound buoys GSK but drugmaker warns on 2017 generic threat

Wed, 08th Feb 2017 13:49

* 2017 core EPS seen flat-lower if mid-year generic Advair

* Current exchange rates would lift 2017 sterling EPS 9 pct

* Q4 2016 core EPS 26.1 pence vs consensus forecast 25.0p (Adds CEO comments, shares, background on new CEO)

By Ben Hirschler

LONDON, Feb 8 (Reuters) - GlaxoSmithKline quarterlysales and profits beat expectations, buoyed by a weak pound, butthe drugmaker warned earnings stripping out currencies couldslip in 2017 if generic copies of its lung drug Advair arrive inthe United States.

Outgoing Chief Executive Andrew Witty, presenting his finalset of results, said the 2017 profit outlook was "veryconsistent" with market consensus and showed GSK was well placedto absorb the potential loss of Advair.

GSK is buttressed by its large consumer health and vaccinesunits, while the core pharmaceuticals business is seeingincreased demand for new drugs.

"Once we are through this window of Advair, the companydoesn't really have any material patent expirations until thelate 2020s, which is an extraordinarily long period of time,"Witty told reporters.

GSK shares slipped around 1 percent following Wednesday'sresults. UBS analyst Michael Leuchten said the 2017 outlookmight cause some confusion but was broadly in line withexpectations.

Quarterly sales rose 21 percent in sterling terms to 7.59billion pounds ($9.48 billion), generating core earnings pershare (EPS) up 45 percent at 26.1 pence.

Analysts, on average, had forecast sales of 7.45 billionpounds and core EPS, which excludes certain items, of 25p,Thomson Reuters data shows.

GSK said EPS, in constant currencies, were set to be flat toslightly lower in 2017, if substitutable generic copies ofAdvair arrive in the United States by mid-year, as most analystsexpect. If generics don't launch, core EPS should increasebetween 5 and 7 percent.

If January 2017 average exchange rates were applied to thewhole of 2017, sterling core EPS would benefit by around 9percent, the group added.

HIGHLY PROFITABLE

GSK has been preparing for the loss of Advair exclusivityfor the past two years but the potential launch of generics willstill be a blow, since the medicine is highly profitable and hassold more than a $1 billion annually since 2001.

The U.S. Food and Drug Administration is due to decidewhether to approve the first substitutable Advair generic, fromMylan, by March 28. A rival version from Hikmaand Vectura has an approval decision date of May 10.

It will be up to Witty's successor Emma Walmsley, 47, tosteer GSK through the challenge when she takes over on April 1.Witty said she was likely to give a strategy update in thesecond half of 2017.

Britain's largest pharmaceuticals company, which generatesmore than 95 percent of its sales overseas, has been one of thebiggest beneficiaries of the pound's sharp depreciation sincelast year's Brexit referendum.

That has cut worries about dividend payouts and lifted thescope for acquisitions, while GSK's high-volume, lower-marginpharma strategy is looking smarter today than a few years backas U.S. President Donald Trump attacks high drug prices.

GSK's upcoming new medicines include a novel inhaler thatcombines three medicines in one device and a promising vaccinefor shingles. But the company also faces competition in itssuccessful HIV business from a new Gilead medicine.

($1 = 0.8005 pounds)

(Reporting by Ben Hirschler; editing by Martinne Geller andSusan Thomas)

More News
21 Mar 2024 16:33

London close: Stocks rise as BoE keeps rates on hold

(Sharecast News) - London markets closed higher on Thursday, sustaining gains after the Bank of England adhered to expectations by maintaining interest rates at a 16-year high.

Read more
14 Mar 2024 15:06

UK dividends calendar - next 7 days

Friday 15 March 
BioPharma Credit PLCdividend payment date
BlackRock Income & Growth Investment Trust PLCdividend payment date
Canadian General Investments Ltddividend payment date
Ecofin US Renewables Infrastructure Trust PLCdividend payment date
Gabelli Merger Plus+ Trust PLCdividend payment date
GCP Asset Backed Income Fund Ltddividend payment date
Impax Environmental Markets PLCdividend payment date
Jersey Electricity PLCdividend payment date
JPMorgan Emerging Europe, Middle East & Africa Securities PLCdividend payment date
Knights Group Holdings PLCdividend payment date
Life Settlement Assets PLCdividend payment date
NCC Group PLCdividend payment date
Northern Bear PLCdividend payment date
Pershing Square Holdings Ltddividend payment date
PetroTal Corpdividend payment date
Schroder UK Mid Cap Fund PLCdividend payment date
Van Elle Holdings PLCdividend payment date
Witan Investment Trust PLCdividend payment date
Monday 18 March 
Aquila European Renewables PLC 
BP Marsh & Partners PLC 
Triple Point Venture VCT PLC 
Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Hongkong Land Holdings Ltdex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Feb 2024 09:18

LONDON BROKER RATINGS: Barclays cuts Direct Line to equal weight

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
29 Feb 2024 07:45

LONDON BRIEFING: Stocks called up following slew of FTSE 100 earnings

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, after a slew of earnings from a range of FTSE 100 companies.

Read more
27 Feb 2024 09:40

Berenberg slightly raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,960.0p to 2,000.0p on Tuesday, citing more stability in its generics unit.

Read more
23 Feb 2024 09:19

LONDON BROKER RATINGS: Barclays raises Breedon but cuts Domino's Pizza

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
22 Feb 2024 16:26

London close: Stocks rise amid raft of solid earnings

(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.

Read more
22 Feb 2024 09:49

LONDON BROKER RATINGS: Berenberg raises Moneysupermarket.com to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.